Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of DYNC1LI2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of DYNC1LI2 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DYNC1LI2 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DYNC1LI2 mRNA | decreases expression | 19150397
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of DYNC1LI2 mRNA | decreases expression | 20678512
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DYNC1LI2 mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DYNC1LI2 mRNA | affects cotreatment|affects expression | 17602206
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of DYNC1LI2 mRNA | increases expression | 12832660
|
D020849 |
Raloxifene |
Raloxifene affects the expression of DYNC1LI2 mRNA | affects expression | 14699072
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of DYNC1LI2 mRNA | decreases expression | 18175754
|
D013619 |
Tacrine |
Tacrine results in increased expression of DYNC1LI2 mRNA | increases expression | 12832660
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
3.63 | 6195326 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.93 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.93 | 19052882 19061943 16434500 17620307 17162532 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
10.93 | 17620307 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.76 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
5.02 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
Tacrine |
5.02 | 12725862 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.00 | 11985600 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.65 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.99 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.99 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.99 | 15775269 17595753 17893378 17261762 17952589 17049068 15572757 17242785 16912660 17440819 15758505 16837676 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.74 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.74 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.74 | 18788625 18971187 20214788 19519916 19701751 16807293 16878318 18785209 16569478 19107877 16935385 20512989 18506893 19822196 3084413 20084675 17055752 20432363 17138121 11831363 19171122 20101231 19052882 17428255 17978847 19335982 10672840 20524982 19539802 18494052 18210153 18691550 16288022 18393292 17173139 20935162 19919837 3581430 19208518 18056438 16540662 19418558 18978308 21159647 16698587 17162532 20514400 16681979 16502159 20007298 16830150 16779866 20727157 10737359 16328049 17761372 19394651 19383236 18665156 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
6.74 | 17173139 20935162 6705139 20007298 1701930 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.18 | 17123778 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.20 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.54 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.74 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.74 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.74 | 17174075 2727394 7505956 21159647 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.43 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.81 | 19052882 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.93 | 15894690 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.79 | 15800139 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.49 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.49 | 18551238 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.29 | 17474826 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.90 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.22 | 20387270 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
4.06 | 17308373 17451421 15920148 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.32 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.32 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.32 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
9.32 | 15131321 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.15 | 1851702 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.47 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.16 | 15845917 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.28 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.09 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.95 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.67 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.43 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.21 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.33 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.10 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.47 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.47 | 17473493 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.63 | 11110106 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
3.66 | 16109766 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.91 | 17577099 15787275 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.44 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.85 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.85 | 14714311 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.76 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.76 | 16705839 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.65 | 16973256 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.88 | 20032147 18407596 19638242 18522880 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.88 | 21047994 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.21 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
4.21 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.14 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
11.14 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
11.14 | 19254457 20501860 19499222 21047994 19638242 19256749 15175105 20118626 19426721 19850985 21278145 2422723 18648771 18978307 18754104 19427195 18644402 9163691 19690152 19833225 12112319 20405173 20101389 19812893 18977376 10737359 12771043 19642983 20137499 19090486 20583210 19073162 19255062 20452335 19294768 20492335 2862719 21071580 19996281 15885732 20434301 19551842 21167192 16942905 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
11.14 | 19812893 15975961 21047994 19482888 8742319 19073162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.36 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.36 | 18093689 19539802 18253720 18775883 21159647 19009564 18544905 16267830 19004024 19519916 18164116 18282651 17942915 9362446 19126423 16842330 18079962 17854601 2563599 17174075 18308698 3124819 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
10.36 | 6150874 17172636 18308698 2563599 1399818 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 6695378 20970405 21163286 20512841 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.21 | 14737004 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.77 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.53 | 16497877 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.67 | 17484760 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.77 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.00 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.00 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.61 | 9029167 3581430 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.13 | 11399458 16427766 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.46 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.33 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.33 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.33 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.56 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.47 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.38 | 15758505 17823083 15579764 17893378 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.18 | 11985600 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.41 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.41 | 16965848 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.51 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.51 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.14 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.35 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.64 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.64 | 16220300 16536755 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.64 | 18760546 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.71 | 12752131 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.98 | 10548101 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.77 | 15770314 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.36 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.36 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
10.36 | 3137016 16876388 4039156 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.02 | 6407741 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.93 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.18 | 16045194 16684133 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.54 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
7.54 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.43 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.64 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.64 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.64 | 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.65 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.65 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.23 | 14652134 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.43 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.77 | 16343187 |